Oncotype DX® Colon Cancer Assay Predicts Risk of Cancer Recurrence external link

Cancer Consultants | Thu, Apr 16

Cancer Consultants is the #6 Blogger for Breast cancer

 ID
According to a press release from Genomic Health, the Oncotype DX® colon cancer assay—a genomic test similar to one already in use for breast cancer—has been shown to predict the risk of cancer recurrence among patients with Stage II colon cancer. ...

[Read original...]

Try These Related Topics

 
 
 

Do you publish a blog? If so, consider joining the Boxxet Network and see your great content showcased and rewarded! Learn more...

©2009 Boxxet, Inc. | Contact | Privacy Policy | Terms of Service
Page updated Fri, Jan 29.